trending Market Intelligence /marketintelligence/en/news-insights/trending/uposufntucy7he2w_uxizg2 content esgSubNav
In This List

Orgenesis raises $5M via placement of shares, warrants

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Orgenesis raises $5M via placement of shares, warrants

Orgenesis Inc. issued 798,803 common shares and warrants to buy 798,803 shares in a private placement.

The warrants have an exercise price of $6.24 each, and are valid for three years.

The company raised proceeds of about $5 million through the placement, which will go toward its global contract development and manufacturing organization network, as well as general corporate purposes.

Germantown, Md.-based Orgenesis develops technologies and provides services related to cell therapy and regenerative medicine.